Drugs / HD-TDV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02425098 | Jun 2015 → Sep 2017 | dengue disease | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HD-TDV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02425098 ↗ |
| Route | Subcutaneous | “HD-TDV 0.5 mL subcutaneous injection” NCT02425098 ↗ |